Insider trade report
Open the filing on sec.gov
IRIDEX Corporation (IRIX)
Nasdaq: IRIX · Electromedical & Electrotherapeutic Apparatus · Mountain View, CA · filing with the SEC since 1996
The companyfiscal 2026, as filed
Revenue$52.7M+8.2%
Net income-$4.4M+50.2%
Earnings per share$-0.26+51.9%
Operating cash flow-$2.1M+71.0%
Cash$6.0M+152.5%
Debtn/a
Shareholders’ equity$4.9M+134.7%
Shares, diluted16.9M+3.0%
Return on equity-90.1%
The recordfrom its filings
Filings in 202656
Newest filingOct 13 · 4
Annual reportApr 2, 2026
Quarterly reportAug 18, 2026
Next report due10-Q by Dec 15
Insider sales, 12 months$0.00
Insider buys, 12 months$200,000
Patents granted48
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jul 2026Revenue $51.6MNet income -$3.5MCash from operations -$1.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.